nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—hematopoietic system—stomach cancer	0.0291	0.0899	CbGeAlD
Amlexanox—IL3—lymphoid tissue—stomach cancer	0.0205	0.0633	CbGeAlD
Amlexanox—IL3—bone marrow—stomach cancer	0.0186	0.0576	CbGeAlD
Amlexanox—IL3—endocrine gland—stomach cancer	0.0167	0.0516	CbGeAlD
Amlexanox—FGF1—blood vessel—stomach cancer	0.016	0.0493	CbGeAlD
Amlexanox—S100A12—hematopoietic system—stomach cancer	0.0136	0.0421	CbGeAlD
Amlexanox—S100A13—epithelium—stomach cancer	0.0126	0.039	CbGeAlD
Amlexanox—S100A12—epithelium—stomach cancer	0.0124	0.0385	CbGeAlD
Amlexanox—S100A13—smooth muscle tissue—stomach cancer	0.0122	0.0376	CbGeAlD
Amlexanox—IL3—lymph node—stomach cancer	0.0115	0.0357	CbGeAlD
Amlexanox—S100A13—digestive system—stomach cancer	0.0096	0.0297	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—stomach cancer	0.00958	0.0296	CbGeAlD
Amlexanox—S100A12—digestive system—stomach cancer	0.00947	0.0293	CbGeAlD
Amlexanox—S100A12—bone marrow—stomach cancer	0.00873	0.027	CbGeAlD
Amlexanox—FGF1—hematopoietic system—stomach cancer	0.00849	0.0263	CbGeAlD
Amlexanox—S100A13—endocrine gland—stomach cancer	0.00793	0.0245	CbGeAlD
Amlexanox—S100A12—endocrine gland—stomach cancer	0.00782	0.0242	CbGeAlD
Amlexanox—FGF1—epithelium—stomach cancer	0.00777	0.024	CbGeAlD
Amlexanox—FGF1—smooth muscle tissue—stomach cancer	0.00748	0.0231	CbGeAlD
Amlexanox—S100A13—liver—stomach cancer	0.00715	0.0221	CbGeAlD
Amlexanox—S100A12—liver—stomach cancer	0.00705	0.0218	CbGeAlD
Amlexanox—FGF1—lymphoid tissue—stomach cancer	0.00598	0.0185	CbGeAlD
Amlexanox—FGF1—digestive system—stomach cancer	0.00591	0.0183	CbGeAlD
Amlexanox—S100A13—lymph node—stomach cancer	0.00548	0.0169	CbGeAlD
Amlexanox—S100A12—lymph node—stomach cancer	0.00541	0.0167	CbGeAlD
Amlexanox—Stomatitis—Floxuridine—stomach cancer	0.00536	0.0563	CcSEcCtD
Amlexanox—FGF1—endocrine gland—stomach cancer	0.00488	0.0151	CbGeAlD
Amlexanox—PDE4B—hematopoietic system—stomach cancer	0.00479	0.0148	CbGeAlD
Amlexanox—PDE4D—liver—stomach cancer	0.00471	0.0145	CbGeAlD
Amlexanox—FGF1—liver—stomach cancer	0.0044	0.0136	CbGeAlD
Amlexanox—Stomatitis—Mitomycin—stomach cancer	0.00421	0.0442	CcSEcCtD
Amlexanox—PDE4B—pancreas—stomach cancer	0.0039	0.0121	CbGeAlD
Amlexanox—PDE4D—lymph node—stomach cancer	0.00361	0.0112	CbGeAlD
Amlexanox—Nervous system disorder—Floxuridine—stomach cancer	0.00344	0.0361	CcSEcCtD
Amlexanox—FGF1—lymph node—stomach cancer	0.00337	0.0104	CbGeAlD
Amlexanox—PDE4B—lymphoid tissue—stomach cancer	0.00337	0.0104	CbGeAlD
Amlexanox—Aphthous stomatitis—Epirubicin—stomach cancer	0.00333	0.035	CcSEcCtD
Amlexanox—Throat sore—Docetaxel—stomach cancer	0.00321	0.0337	CcSEcCtD
Amlexanox—PDE4A—lymph node—stomach cancer	0.00319	0.00987	CbGeAlD
Amlexanox—Oropharyngeal discomfort—Docetaxel—stomach cancer	0.00319	0.0334	CcSEcCtD
Amlexanox—Throat sore—Capecitabine—stomach cancer	0.00311	0.0327	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Capecitabine—stomach cancer	0.00308	0.0324	CcSEcCtD
Amlexanox—Aphthous stomatitis—Doxorubicin—stomach cancer	0.00308	0.0324	CcSEcCtD
Amlexanox—PDE4B—bone marrow—stomach cancer	0.00307	0.0095	CbGeAlD
Amlexanox—PDE4B—endocrine gland—stomach cancer	0.00275	0.00851	CbGeAlD
Amlexanox—Oropharyngeal pain—Docetaxel—stomach cancer	0.00255	0.0267	CcSEcCtD
Amlexanox—PDE4B—liver—stomach cancer	0.00248	0.00767	CbGeAlD
Amlexanox—Oropharyngeal pain—Capecitabine—stomach cancer	0.00247	0.0259	CcSEcCtD
Amlexanox—Pain—Mitomycin—stomach cancer	0.00235	0.0247	CcSEcCtD
Amlexanox—Headache—Floxuridine—stomach cancer	0.0022	0.0231	CcSEcCtD
Amlexanox—Nausea—Floxuridine—stomach cancer	0.00208	0.0219	CcSEcCtD
Amlexanox—Mouth ulceration—Capecitabine—stomach cancer	0.00203	0.0213	CcSEcCtD
Amlexanox—PDE4B—lymph node—stomach cancer	0.0019	0.00588	CbGeAlD
Amlexanox—Stomatitis—Irinotecan—stomach cancer	0.00183	0.0192	CcSEcCtD
Amlexanox—Stomatitis—Fluorouracil—stomach cancer	0.00175	0.0184	CcSEcCtD
Amlexanox—Headache—Mitomycin—stomach cancer	0.00172	0.0181	CcSEcCtD
Amlexanox—Nausea—Mitomycin—stomach cancer	0.00164	0.0172	CcSEcCtD
Amlexanox—Liver function test abnormal—Docetaxel—stomach cancer	0.00155	0.0163	CcSEcCtD
Amlexanox—Mouth ulceration—Methotrexate—stomach cancer	0.00151	0.0158	CcSEcCtD
Amlexanox—Liver function test abnormal—Capecitabine—stomach cancer	0.0015	0.0158	CcSEcCtD
Amlexanox—Mouth ulceration—Epirubicin—stomach cancer	0.00141	0.0148	CcSEcCtD
Amlexanox—Mouth ulceration—Doxorubicin—stomach cancer	0.00131	0.0137	CcSEcCtD
Amlexanox—Stomatitis—Docetaxel—stomach cancer	0.00126	0.0133	CcSEcCtD
Amlexanox—Stomatitis—Capecitabine—stomach cancer	0.00122	0.0128	CcSEcCtD
Amlexanox—Nervous system disorder—Irinotecan—stomach cancer	0.00117	0.0123	CcSEcCtD
Amlexanox—Nervous system disorder—Fluorouracil—stomach cancer	0.00112	0.0118	CcSEcCtD
Amlexanox—Liver function test abnormal—Methotrexate—stomach cancer	0.00112	0.0117	CcSEcCtD
Amlexanox—Paraesthesia—Irinotecan—stomach cancer	0.00107	0.0113	CcSEcCtD
Amlexanox—Liver function test abnormal—Epirubicin—stomach cancer	0.00105	0.011	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00103	0.0108	CcSEcCtD
Amlexanox—Paraesthesia—Fluorouracil—stomach cancer	0.00103	0.0108	CcSEcCtD
Amlexanox—Pain—Irinotecan—stomach cancer	0.00102	0.0107	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000989	0.0104	CcSEcCtD
Amlexanox—Pain—Fluorouracil—stomach cancer	0.000979	0.0103	CcSEcCtD
Amlexanox—Liver function test abnormal—Doxorubicin—stomach cancer	0.000969	0.0102	CcSEcCtD
Amlexanox—Stomatitis—Methotrexate—stomach cancer	0.00091	0.00956	CcSEcCtD
Amlexanox—Stomatitis—Epirubicin—stomach cancer	0.000852	0.00894	CcSEcCtD
Amlexanox—Nervous system disorder—Docetaxel—stomach cancer	0.00081	0.00851	CcSEcCtD
Amlexanox—Stomatitis—Doxorubicin—stomach cancer	0.000788	0.00828	CcSEcCtD
Amlexanox—Nervous system disorder—Capecitabine—stomach cancer	0.000785	0.00824	CcSEcCtD
Amlexanox—Headache—Irinotecan—stomach cancer	0.000749	0.00786	CcSEcCtD
Amlexanox—Paraesthesia—Docetaxel—stomach cancer	0.000742	0.00779	CcSEcCtD
Amlexanox—Paraesthesia—Capecitabine—stomach cancer	0.000718	0.00754	CcSEcCtD
Amlexanox—Headache—Fluorouracil—stomach cancer	0.000717	0.00753	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000713	0.00749	CcSEcCtD
Amlexanox—Nausea—Irinotecan—stomach cancer	0.00071	0.00746	CcSEcCtD
Amlexanox—Pain—Docetaxel—stomach cancer	0.000707	0.00742	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000691	0.00725	CcSEcCtD
Amlexanox—Pain—Capecitabine—stomach cancer	0.000684	0.00718	CcSEcCtD
Amlexanox—Nausea—Fluorouracil—stomach cancer	0.00068	0.00714	CcSEcCtD
Amlexanox—Nervous system disorder—Methotrexate—stomach cancer	0.000584	0.00613	CcSEcCtD
Amlexanox—Nervous system disorder—Epirubicin—stomach cancer	0.000547	0.00574	CcSEcCtD
Amlexanox—Paraesthesia—Methotrexate—stomach cancer	0.000535	0.00562	CcSEcCtD
Amlexanox—Headache—Docetaxel—stomach cancer	0.000518	0.00544	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000514	0.0054	CcSEcCtD
Amlexanox—Pain—Methotrexate—stomach cancer	0.000509	0.00535	CcSEcCtD
Amlexanox—Nervous system disorder—Doxorubicin—stomach cancer	0.000506	0.00531	CcSEcCtD
Amlexanox—Headache—Capecitabine—stomach cancer	0.000501	0.00526	CcSEcCtD
Amlexanox—Paraesthesia—Epirubicin—stomach cancer	0.000501	0.00526	CcSEcCtD
Amlexanox—Nausea—Docetaxel—stomach cancer	0.000491	0.00515	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000481	0.00505	CcSEcCtD
Amlexanox—Pain—Epirubicin—stomach cancer	0.000477	0.005	CcSEcCtD
Amlexanox—Nausea—Capecitabine—stomach cancer	0.000475	0.00499	CcSEcCtD
Amlexanox—Paraesthesia—Doxorubicin—stomach cancer	0.000463	0.00486	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000445	0.00468	CcSEcCtD
Amlexanox—Pain—Doxorubicin—stomach cancer	0.000441	0.00463	CcSEcCtD
Amlexanox—Headache—Methotrexate—stomach cancer	0.000373	0.00392	CcSEcCtD
Amlexanox—Nausea—Methotrexate—stomach cancer	0.000354	0.00371	CcSEcCtD
Amlexanox—Headache—Epirubicin—stomach cancer	0.000349	0.00367	CcSEcCtD
Amlexanox—Nausea—Epirubicin—stomach cancer	0.000331	0.00348	CcSEcCtD
Amlexanox—Headache—Doxorubicin—stomach cancer	0.000323	0.00339	CcSEcCtD
Amlexanox—Nausea—Doxorubicin—stomach cancer	0.000306	0.00322	CcSEcCtD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL8—stomach cancer	5.76e-05	9.9e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PRKCB—stomach cancer	5.71e-05	9.83e-05	CbGpPWpGaD
Amlexanox—IL3—Immune System—HRAS—stomach cancer	5.71e-05	9.82e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK1—stomach cancer	5.7e-05	9.8e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—stomach cancer	5.69e-05	9.8e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6ST—stomach cancer	5.69e-05	9.79e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—stomach cancer	5.69e-05	9.78e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1A—stomach cancer	5.66e-05	9.75e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—stomach cancer	5.65e-05	9.72e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CASP8—stomach cancer	5.63e-05	9.69e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6R—stomach cancer	5.62e-05	9.66e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGFR2—stomach cancer	5.6e-05	9.64e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK1—stomach cancer	5.59e-05	9.61e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—stomach cancer	5.59e-05	9.61e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—APC—stomach cancer	5.58e-05	9.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDH1—stomach cancer	5.57e-05	9.57e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK8—stomach cancer	5.53e-05	9.51e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FYN—stomach cancer	5.52e-05	9.5e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APC—stomach cancer	5.47e-05	9.41e-05	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—stomach cancer	5.46e-05	9.39e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMAD4—stomach cancer	5.42e-05	9.33e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IRS2—stomach cancer	5.39e-05	9.27e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—KRAS—stomach cancer	5.38e-05	9.25e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—stomach cancer	5.37e-05	9.23e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—KRAS—stomach cancer	5.28e-05	9.08e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK3—stomach cancer	5.24e-05	9.01e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CAV1—stomach cancer	5.23e-05	8.99e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—stomach cancer	5.23e-05	8.99e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOA1—stomach cancer	5.21e-05	8.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGFR2—stomach cancer	5.18e-05	8.92e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6R—stomach cancer	5.18e-05	8.92e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FYN—stomach cancer	5.15e-05	8.86e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IRS2—stomach cancer	5.13e-05	8.83e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—stomach cancer	5.11e-05	8.78e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6R—stomach cancer	5.08e-05	8.74e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—KRAS—stomach cancer	5.07e-05	8.72e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—STAT3—stomach cancer	5.05e-05	8.7e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK1—stomach cancer	4.98e-05	8.57e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—stomach cancer	4.98e-05	8.57e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CAV1—stomach cancer	4.98e-05	8.56e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PRKCB—stomach cancer	4.97e-05	8.56e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOA1—stomach cancer	4.96e-05	8.54e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6ST—stomach cancer	4.95e-05	8.52e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PIK3CA—stomach cancer	4.94e-05	8.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—SERPINE1—stomach cancer	4.85e-05	8.35e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PIK3CA—stomach cancer	4.85e-05	8.34e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGFR2—stomach cancer	4.83e-05	8.32e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK3—stomach cancer	4.83e-05	8.31e-05	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—PIK3CA—stomach cancer	4.76e-05	8.19e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APC—stomach cancer	4.76e-05	8.19e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SERPINE1—stomach cancer	4.76e-05	8.18e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IRS2—stomach cancer	4.75e-05	8.17e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRKCB—stomach cancer	4.74e-05	8.15e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6ST—stomach cancer	4.72e-05	8.11e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—KRAS—stomach cancer	4.71e-05	8.1e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—stomach cancer	4.7e-05	8.08e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB2—stomach cancer	4.7e-05	8.08e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—RHOA—stomach cancer	4.68e-05	8.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PIK3CA—stomach cancer	4.66e-05	8.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—stomach cancer	4.63e-05	7.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CAV1—stomach cancer	4.6e-05	7.92e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK1—stomach cancer	4.6e-05	7.9e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—stomach cancer	4.59e-05	7.9e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOA1—stomach cancer	4.59e-05	7.9e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RHOA—stomach cancer	4.59e-05	7.89e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HRAS—stomach cancer	4.57e-05	7.87e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK3—stomach cancer	4.56e-05	7.84e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—stomach cancer	4.54e-05	7.81e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APC—stomach cancer	4.53e-05	7.8e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—HRAS—stomach cancer	4.49e-05	7.72e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IRS2—stomach cancer	4.43e-05	7.62e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6R—stomach cancer	4.42e-05	7.61e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRKCB—stomach cancer	4.38e-05	7.54e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—stomach cancer	4.38e-05	7.53e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6ST—stomach cancer	4.36e-05	7.51e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1B—stomach cancer	4.35e-05	7.48e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK3—stomach cancer	4.34e-05	7.47e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KRAS—stomach cancer	4.34e-05	7.47e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK1—stomach cancer	4.34e-05	7.46e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—stomach cancer	4.34e-05	7.46e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB2—stomach cancer	4.34e-05	7.46e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PIK3CA—stomach cancer	4.32e-05	7.44e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HRAS—stomach cancer	4.31e-05	7.41e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—stomach cancer	4.29e-05	7.39e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CAV1—stomach cancer	4.29e-05	7.38e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOA1—stomach cancer	4.28e-05	7.37e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—stomach cancer	4.27e-05	7.35e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB2—stomach cancer	4.25e-05	7.31e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—stomach cancer	4.24e-05	7.29e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6R—stomach cancer	4.21e-05	7.24e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APC—stomach cancer	4.19e-05	7.21e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—PIK3CA—stomach cancer	4.15e-05	7.13e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SERPINE1—stomach cancer	4.14e-05	7.12e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JUN—stomach cancer	4.14e-05	7.12e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK1—stomach cancer	4.13e-05	7.1e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—stomach cancer	4.13e-05	7.1e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—KRAS—stomach cancer	4.1e-05	7.05e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRKCB—stomach cancer	4.09e-05	7.03e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6ST—stomach cancer	4.07e-05	7e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—stomach cancer	4.03e-05	6.93e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK3—stomach cancer	4.02e-05	6.91e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1B—stomach cancer	4.01e-05	6.91e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1A—stomach cancer	4.01e-05	6.9e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HRAS—stomach cancer	4e-05	6.88e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RHOA—stomach cancer	3.99e-05	6.87e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PIK3CA—stomach cancer	3.99e-05	6.86e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—stomach cancer	3.95e-05	6.8e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—PIK3CA—stomach cancer	3.95e-05	6.79e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SERPINE1—stomach cancer	3.94e-05	6.78e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1B—stomach cancer	3.93e-05	6.77e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK8—stomach cancer	3.92e-05	6.74e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APC—stomach cancer	3.91e-05	6.73e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—KRAS—stomach cancer	3.9e-05	6.71e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6R—stomach cancer	3.89e-05	6.7e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—stomach cancer	3.86e-05	6.64e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—stomach cancer	3.83e-05	6.59e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK1—stomach cancer	3.82e-05	6.57e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—stomach cancer	3.82e-05	6.57e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RHOA—stomach cancer	3.8e-05	6.54e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PIK3CA—stomach cancer	3.76e-05	6.48e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—stomach cancer	3.76e-05	6.47e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—stomach cancer	3.75e-05	6.45e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JUN—stomach cancer	3.74e-05	6.44e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1A—stomach cancer	3.71e-05	6.37e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB2—stomach cancer	3.7e-05	6.36e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HRAS—stomach cancer	3.69e-05	6.35e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PIK3CA—stomach cancer	3.65e-05	6.28e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SERPINE1—stomach cancer	3.65e-05	6.27e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—stomach cancer	3.64e-05	6.27e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6R—stomach cancer	3.63e-05	6.25e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1A—stomach cancer	3.63e-05	6.24e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—KRAS—stomach cancer	3.61e-05	6.21e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PIK3CA—stomach cancer	3.58e-05	6.16e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—stomach cancer	3.58e-05	6.16e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK8—stomach cancer	3.54e-05	6.09e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—stomach cancer	3.53e-05	6.07e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB2—stomach cancer	3.52e-05	6.05e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RHOA—stomach cancer	3.52e-05	6.05e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—stomach cancer	3.51e-05	6.03e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HRAS—stomach cancer	3.48e-05	5.99e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—stomach cancer	3.48e-05	5.99e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1B—stomach cancer	3.42e-05	5.89e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK3—stomach cancer	3.42e-05	5.89e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SERPINE1—stomach cancer	3.4e-05	5.85e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—stomach cancer	3.34e-05	5.74e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—stomach cancer	3.33e-05	5.73e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CA—stomach cancer	3.32e-05	5.7e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HRAS—stomach cancer	3.32e-05	5.7e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—stomach cancer	3.31e-05	5.69e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RHOA—stomach cancer	3.28e-05	5.64e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—stomach cancer	3.27e-05	5.63e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—stomach cancer	3.27e-05	5.62e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JUN—stomach cancer	3.26e-05	5.61e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1B—stomach cancer	3.26e-05	5.61e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB2—stomach cancer	3.26e-05	5.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK1—stomach cancer	3.26e-05	5.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—stomach cancer	3.25e-05	5.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—stomach cancer	3.25e-05	5.58e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—stomach cancer	3.24e-05	5.57e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—stomach cancer	3.17e-05	5.46e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—stomach cancer	3.17e-05	5.45e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1A—stomach cancer	3.16e-05	5.44e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK3—stomach cancer	3.16e-05	5.43e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—stomach cancer	3.11e-05	5.35e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JUN—stomach cancer	3.1e-05	5.34e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK3—stomach cancer	3.09e-05	5.32e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—stomach cancer	3.09e-05	5.31e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK8—stomach cancer	3.08e-05	5.31e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KRAS—stomach cancer	3.07e-05	5.29e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—stomach cancer	3.07e-05	5.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HRAS—stomach cancer	3.07e-05	5.28e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB2—stomach cancer	3.04e-05	5.22e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—stomach cancer	3.02e-05	5.19e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1B—stomach cancer	3.02e-05	5.19e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—stomach cancer	3.01e-05	5.18e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1A—stomach cancer	3.01e-05	5.17e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK1—stomach cancer	3.01e-05	5.17e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—stomach cancer	3e-05	5.17e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK1—stomach cancer	2.94e-05	5.06e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—stomach cancer	2.94e-05	5.06e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—stomach cancer	2.94e-05	5.05e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK8—stomach cancer	2.94e-05	5.05e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—stomach cancer	2.88e-05	4.95e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—stomach cancer	2.88e-05	4.95e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JUN—stomach cancer	2.87e-05	4.94e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—stomach cancer	2.85e-05	4.9e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—KRAS—stomach cancer	2.84e-05	4.88e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PIK3CA—stomach cancer	2.82e-05	4.86e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—stomach cancer	2.82e-05	4.85e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1B—stomach cancer	2.81e-05	4.84e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—stomach cancer	2.79e-05	4.8e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1A—stomach cancer	2.78e-05	4.79e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KRAS—stomach cancer	2.78e-05	4.78e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK8—stomach cancer	2.72e-05	4.67e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—stomach cancer	2.71e-05	4.66e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK3—stomach cancer	2.69e-05	4.63e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—stomach cancer	2.68e-05	4.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—stomach cancer	2.68e-05	4.61e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JUN—stomach cancer	2.68e-05	4.6e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—stomach cancer	2.62e-05	4.51e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HRAS—stomach cancer	2.61e-05	4.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PIK3CA—stomach cancer	2.61e-05	4.49e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—stomach cancer	2.6e-05	4.48e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1A—stomach cancer	2.59e-05	4.46e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK3—stomach cancer	2.56e-05	4.41e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK1—stomach cancer	2.56e-05	4.41e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—stomach cancer	2.56e-05	4.41e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CA—stomach cancer	2.55e-05	4.39e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK8—stomach cancer	2.53e-05	4.36e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—stomach cancer	2.51e-05	4.31e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—stomach cancer	2.5e-05	4.3e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—stomach cancer	2.49e-05	4.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—stomach cancer	2.48e-05	4.27e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—stomach cancer	2.47e-05	4.25e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK1—stomach cancer	2.44e-05	4.2e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—stomach cancer	2.44e-05	4.2e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KRAS—stomach cancer	2.42e-05	4.16e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—HRAS—stomach cancer	2.41e-05	4.15e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK3—stomach cancer	2.37e-05	4.08e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HRAS—stomach cancer	2.36e-05	4.07e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—stomach cancer	2.34e-05	4.02e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—stomach cancer	2.32e-05	3.98e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—stomach cancer	2.31e-05	3.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—stomach cancer	2.31e-05	3.97e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KRAS—stomach cancer	2.3e-05	3.96e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—stomach cancer	2.26e-05	3.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK1—stomach cancer	2.26e-05	3.88e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—stomach cancer	2.26e-05	3.88e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CA—stomach cancer	2.22e-05	3.83e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK3—stomach cancer	2.21e-05	3.81e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—stomach cancer	2.15e-05	3.7e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—stomach cancer	2.15e-05	3.7e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KRAS—stomach cancer	2.13e-05	3.67e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CA—stomach cancer	2.12e-05	3.64e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK1—stomach cancer	2.1e-05	3.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—stomach cancer	2.1e-05	3.62e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HRAS—stomach cancer	2.06e-05	3.54e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—stomach cancer	2.05e-05	3.52e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KRAS—stomach cancer	1.99e-05	3.42e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—stomach cancer	1.97e-05	3.39e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CA—stomach cancer	1.96e-05	3.37e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HRAS—stomach cancer	1.96e-05	3.37e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—stomach cancer	1.89e-05	3.26e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—stomach cancer	1.87e-05	3.22e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CA—stomach cancer	1.83e-05	3.14e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HRAS—stomach cancer	1.81e-05	3.12e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—stomach cancer	1.77e-05	3.04e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—stomach cancer	1.73e-05	2.98e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HRAS—stomach cancer	1.69e-05	2.91e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—stomach cancer	1.62e-05	2.78e-05	CbGpPWpGaD
